1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-18.95%
Cash & equivalents declining -18.95% while CSIQ's grows 8.98%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
-96.67%
Both CSIQ and the company show zero Short-Term Investments Growth.
-18.95%
Below half of CSIQ's 9.12%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
25.27%
Similar receivables growth to CSIQ's 33.17%. Walter Schloss would see comparable credit policies, investigating any subtle differences in sales.
24.66%
Inventory growth above 1.5x CSIQ's 5.47%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
416.78%
Above 1.5x CSIQ's 31.74%. Michael Burry might investigate for potential short-term asset misclassification or risk.
17.64%
0.75-0.9x CSIQ's 21.01%. Bill Ackman would ask if competitor is building short-term resources more aggressively.
3.25%
1.25-1.5x CSIQ's 2.70%. Bruce Berkowitz notes a significant push to expand capacity faster than competitor.
66.96%
Higher Goodwill Growth compared to CSIQ's zero value, indicating worse performance.
-14.61%
Less than half of CSIQ's 19.85%. David Dodd sees relatively fewer intangible expansions. Possibly more tangible-driven.
57.83%
Above 1.5x CSIQ's 19.85%. Michael Burry sees potential overpaying or intangible bubble risk. Check synergy assumptions.
10.67%
Below half of CSIQ's 500.75%. Michael Burry sees possible underinvestment in long-term assets. Verify capital constraints.
18232.75%
Above 1.5x CSIQ's 4.48%. Michael Burry suspects major tax losses or deferrals building up, raising concerns about sustained profitability.
46.65%
Less than half of CSIQ's -100.00%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
26.22%
≥ 1.5x CSIQ's 2.59%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
22.14%
1.25-1.5x CSIQ's 15.96%. Bruce Berkowitz sees a stronger asset build. Check if it's producing returns.
9.52%
Above 1.5x CSIQ's 1.54%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
29.22%
50-75% of CSIQ's 43.80%. Bruce Berkowitz notes the firm is less reliant on near-term borrowing than competitor.
-33.00%
Higher Tax Payables Growth compared to CSIQ's zero value, indicating worse performance.
-100.00%
Below half of CSIQ's 111.18%. Michael Burry suspects a big gap in pre-sales traction.
-31.91%
Less than half of CSIQ's 8.68%. David Dodd sees fewer expansions in other current obligations.
16.11%
50-75% of CSIQ's 31.13%. Bruce Berkowitz notes the firm keeps current liabilities growth relatively low.
47.21%
Less than half of CSIQ's -4.80%. David Dodd sees more deleveraging vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-16.47%
Less than half of CSIQ's 3.84%. David Dodd sees fewer additions to deferred tax liabilities vs. competitor.
120.06%
Above 1.5x CSIQ's 19.90%. Michael Burry suspects a looming risk from large additions to LT liabilities.
59.86%
Above 1.5x CSIQ's 4.03%. Michael Burry sees a strong spike vs. competitor. Check coverage and debt ratios.
No Data
No Data available this quarter, please select a different quarter.
41.63%
1.25-1.5x CSIQ's 28.39%. Martin Whitman is wary of bigger liability expansions.
No Data
No Data available this quarter, please select a different quarter.
11.00%
0.75-0.9x CSIQ's 12.97%. Bill Ackman questions if competitor reinvests profits more robustly.
118.49%
Above 1.5x CSIQ's 0.23%. Michael Burry sees a significant jump in intangible or market-based gains. Scrutinize risk of reversal.
-100.00%
Less than half of CSIQ's 100.00%. David Dodd notes simpler yoy equity changes vs. competitor.
3.36%
≥ 1.5x CSIQ's 0.71%. David Dodd sees stronger capital base growth than competitor.
22.14%
1.25-1.5x CSIQ's 15.96%. Bruce Berkowitz checks if expansions are well-justified by ROI.
10.63%
Below half CSIQ's 504.07%. Michael Burry suspects major underinvestment or forced divestment.
43.80%
Similar yoy changes to CSIQ's 40.02%. Walter Schloss notes parallel total debt strategies.
271.59%
Above 1.5x CSIQ's 61.91%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.